Under the new regulation, medtech manufacturers can no longer defend their claims with limited clinical data; the depth, breadth and scrutiny on clinical data is much more rigorous.
To achieve success in this market, device manufacturers should consider working with providers to help contain costs and enhance outcomes.
Achieving EU MDR compliance is considerably challenging for many businesses, which is why they must be discerning when it comes to selecting suitable partners.
Leveraging automation and data analytics can help facilitate innovation and financial stability.
Part II reviews some lessons learned as we try to predict the trajectory and defenses to COVID-19 test cases.
Monitoring patients through distributed technology will be key to restoring its health.
Part one of this series looks at the claims brought against manufacturers of diagnostic test kits.
During product development, collaboration between software, hardware and quality teams must be tracked and seamless to meet the increasing pace of market demand.
Across our industry, IoMT will enable us to conduct research in ways that would never previously have been possible.
With everything to gain, telehealth may lead to a new standard in health/wellness treatment while at the same time unifying the entire healthcare ecosystem.